0001567619-20-006723.txt : 20200318
0001567619-20-006723.hdr.sgml : 20200318
20200318204635
ACCESSION NUMBER: 0001567619-20-006723
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200316
FILED AS OF DATE: 20200318
DATE AS OF CHANGE: 20200318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWLIS V BRYAN
CENTRAL INDEX KEY: 0001247681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 20726211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-03-16
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001247681
LAWLIS V BRYAN
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO
CA
94949
1
0
0
0
Common Stock
2020-03-16
4
S
0
4610
76.52
D
18980
D
Common Stock
2020-03-17
4
M
0
3750
21.51
A
22730
D
Common Stock
2020-03-17
4
S
0
3750
75.39
D
18980
D
Stock Option (Right to buy Common Stock)
21.510
2020-03-17
4
M
0
3750
0
D
2010-11-12
2020-05-11
Common Stock
3750
0
D
Trade made pursuant to a 10b5-1 plan executed on January 16, 2020.
Trade made pursuant to a 10b5-1 plan executed on May 1, 2019.
Reflects the number of options outstanding after the transactions from the specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2020-03-18